46 studies found for:    Open Studies | "Helicobacter Infections"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Helicobacter Infections" (46 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Comparison of 7-Day and 14-Day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
Condition: Helicobacter Infection
Interventions: Drug: pantoprazole;   Drug: bismuth;   Drug: metronidazole;   Drug: tetracycline
2 Unknown  Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
Condition: Helicobacter Infection
Interventions: Drug: Standard Triple Therapy;   Drug: Sequential Therapy
3 Recruiting The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection
Condition: Helicobacter Infection
Interventions: Drug: 10 day sequential therapy (Esomeprazole, amoxicillin, clarithromycin, metronidazole);   Procedure: 7 day tailored therapy based on antimicrobial susceptibility testing;   Drug: PPI based triple therapy [Esomeprazole, amoxicillin, clarithromycin];   Drug: bismuth quadruple therapy [Esomeprazole, Tri potassium dicitrate bismuthate, Metronidazole, Tetracycline];   Drug: moxifloxacin triple therapy [Esomeprazole, Moxifloxacin, Amoxicillin]
4 Recruiting The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
Condition: Helicobacter Infection
Interventions: Procedure: H. pylori culture and antimicrobial susceptibility testing;   Drug: 14 days empirical bismuth quadruple therapy (Proton pump inhibitor);   Drug: Metronidazole;   Drug: Tetracycline;   Drug: tripotassium dicitrate bismuthate;   Drug: 7 days tailored therapy Proton Pump Inhibitor;   Drug: Moxifloxacin;   Drug: Amoxicillin
5 Unknown  Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
Conditions: Parkinson's Disease;   Helicobacter Infections;   Motor Fluctuations
Interventions: Drug: clartihromycin, amoxicillin, and omeprazole;   Drug: placebo
6 Unknown  Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: Lansoprazole, clarithromycin, amoxicillin
7 Recruiting Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection
Condition: Helicobacter Infections
Intervention: Drug: Ilaprazole + Amoxicillin
8 Not yet recruiting Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy
Condition: Helicobacter Infections
Interventions: Procedure: Gastroscopy;   Device: EndoFaster test;   Other: Clo test;   Other: Faecal Helicobacter pylori antigen
9 Recruiting Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori
Condition: Helicobacter Infections
Interventions: Drug: Noltec tab. 10mg;   Drug: Chongkundang Amoxicillin Cap. 500mg;   Drug: Cravit Tab. 500mg
10 Unknown  Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole, amoxicillin, clarithromycin, metronidazole
11 Unknown  Immediate Detection of Helicobacter Infection With a New Electrochemical System.
Condition: H. Pylori Infection
Interventions: Device: Electrochemical H. pylori detection method;   Device: IHC;   Device: C13-urea breath test;   Device: HUT
12 Unknown  Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
Conditions: Helicobacter Pylori Infection;   Chronic Gastritis
Interventions: Drug: esomeprazole;   Drug: moxifloxacin;   Drug: amoxicillin
13 Recruiting Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Intervention: Drug: triple, quadruple, non-bismuth quadruple therapy
14 Unknown  Concomitant, Sequential, and Standard Triple Therapy for H. Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: 7-day quadruple therapy;   Drug: 10-day sequential therapy;   Drug: 7-day standard triple therapy
15 Not yet recruiting The Diagnostic Validity of the Urea Breath Test
Condition: Helicobacter Pylori Infection
Intervention: Drug: Citric acid
16 Unknown  Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: high dose dual therapy;   Drug: concomitant therapy
17 Recruiting ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
Conditions: Dyspepsia;   Helicobacter Pylori Infection
Interventions: Drug: RHB-105;   Drug: Placebo
18 Recruiting Volatile Markers in Digestive Cancer
Conditions: Colorectal Cancer;   Colorectal Adenoma;   Gastric Cancer;   Peptic Ulcer Disease;   Atrophic Gastritis;   Intestinal Metaplasia;   H.Pylori Infection;   Normal Control;   Average-risk General Population
Interventions: Procedure: Breath sampling for volatile marker detection;   Procedure: Upper endoscopy with biopsies;   Procedure: Colonoscopy with biopsies or lesion removal when required;   Procedure: Plasma/serum sampling;   Procedure: Faecal sample acquisition;   Procedure: Histological evaluation of the surgery material
19 Unknown  Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Dietary Supplement: InSan Bamboo Salt;   Dietary Supplement: Placebo
20 Unknown  H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study
Condition: H. Pylori Infection
Intervention: Drug: bismuth subcitrate potassium, metronidazole,tetracycline hydrochloride and omeprazole

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years